Trials / Terminated
TerminatedNCT02872649
Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)
Pilot-Trial: Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Daniel Zimpfer, MD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with severe heart failure supported by left ventricular assist device (LVAD) require adequate long-term anticoagulant therapy. New oral anticoagulants such as the direct thrombin inhibitor dabigatran may represent an alternative to Coumarin for long-term anticoagulation. In this pilot single-center study, thirty LVAD patients with stable renal function were scheduled to receive phenprocoumon or dabigatran for long-term anticoagulation after implantation of a HeartWare HVAD system following an open-label balanced parallel group design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dabigatran | |
| DRUG | Phenprocoumon |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-06-01
- Completion
- 2016-02-01
- First posted
- 2016-08-19
- Last updated
- 2016-08-19
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02872649. Inclusion in this directory is not an endorsement.